FDA Approvals

[2015-Feb-23] FDA approves Farydak for treatment of multiple myeloma

아편굴 2015. 2. 28. 22:33

[2015-Feb-23] FDA approves Farydak for treatment of multiple myeloma

http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm435296.htm




Farydak.cdx


M. Cecilia Crisanti, Africa F. Wallace, Veena Kapoor, Fabian Vandermeers, Melissa L. Dowling, Luana P. Pereira, Kara Coleman, Barbara G. Campling, Zvi G. Fridlender, Gary D. Kao and Steven M. Albelda, The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer, Mol. Cancer Ther., 2009, 8 (8), pp 2221-2231

http://dx.doi.org/10.1158/1535-7163.MCT-09-0138


Jessica E. Bolden, Melissa J. Peart and Ricky W. Johnstone, Anticancer activities of histone deacetylase inhibitors, Nat. Rev. Drug Discov., 2006, 5 (9), pp 769-784

http://dx.doi.org/10.1038/nrd2133

저작자표시